## Abstract Postmenopausal hormone therapy (HT) is associated with increased risk of breast cancer, but in women undergoing breast cancer screening it is not clear whether use of HT is associated with increased risk of breast cancer detected at screening or between screens (interval cancer). Furthe
Impact of mammographic screening on the detection of good and poor prognosis breast cancers
✍ Scribed by Laura J. Esserman; Yiwey Shieh; Emiel J. T. Rutgers; Michael Knauer; Valesca P. Retèl; Stella Mook; Annuska M. Glas; Dan H. Moore; Sabine Linn; Flora E. van Leeuwen; Laura J. van ’t Veer
- Publisher
- Springer US
- Year
- 2011
- Tongue
- English
- Weight
- 441 KB
- Volume
- 130
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Although many studies support the life-saving potential of screening mammography, the actual utilization of screening and the impact of the actual pattern of screening use on the breast carcinoma death rate, remain incompletely understood. in the current report, the authors describe
## Abstract ## BACKGROUND Previous results have shown a reduction in mortality with service screening in Sweden on the order of 40%. If the rate of tumors at a later stage were similarly reduced, this would give further support to the mortality findings. ## METHODS The rates of lymph node‐positi
## Abstract ## BACKGROUND The introduction of breast carcinoma screening leads to early detection and is believed to reduce mortality and increase the proportion of patients for whom breast‐conserving surgery is possible. ## METHODS In 1992, a population‐based mammographic screening program was
To examine the use of mammographic screening in women in New South Wales (NSW), we measured uptake of initial mammograms and estimated the proportions of breast cancers that were screen detected. To see if mammographic screening has been associated with reductions in advanced breast cancers and mort